Effectiveness of serological markers of gastric mucosal atrophy in the gastric precancer screening and in cancer prevention

Table 6 Dynamics of multifocal atrophic gastritis of the patient

Observa-tion time	Patient age	Histological atrophy (Sydney system)					Gastrin-17 pmol/L postprand
		Biopsy 1: Antrum	Biopsy 2: Antrum	Biopsy 3: Incisura angul	Biopsy 4: Corpus	Biopsy 5: Corpus
2017	63	Mild	Absent	Mild	Mild	Absent	7.2
2018	64	Mild	Absent	Mild	Mild	Absent	8.6
2019	65	Mild	Mild	Mild	Absent	Absent	7.4
2020	66	Mild	Absent	Absent	Absent	Mild	10.9
2021	67	Mild	Mild	Mild	Absent	Absent	17.5
2022	68	Mild	Mild	Mild	Mild	Absent	15.5
2023	69	-	-	-	-	-	14.6